Global Virtual Clinical Trials Market estimated close to $8 Billion (2020), growing above 10% CAGR

Medi-Tech Insights offers a latest research report on Virtual Clinical Trials Market with detailed insights on all the key market players and important market segments.
 
BRUSSELS - April 4, 2022 - PRLog -- A virtual clinical trial (also known as remote/decentralized clinical trials) refers to digitally empowered clinical trial processes. The market growth is driven by increasing adoption of virtual trials following outbreak of COVID-19 pandemic.

Virtual trials enable easy Patient Enrolment and Remote Monitoring

Virtual trials are based on telemedicine and use dedicated apps for patient engagement and tracking. They greatly reduce the financial and time burdens. In addition, use of AI technologies can help synthesize and analyze ever-expanding data and speed up the process. Such benefits are increasingly drawing interest of life science companies/clinical trials sponsors into virtual clinical trials.

"AI likely to play important role in virtual clinical trials. Conversational AI for natural language processing (NLP) and image-based AI will increasingly become part of virtual trials. Conversational AI help maintain the patient-clinician engagement while imaging AI to play key role in trials that require radiology" – CTO, Leading Clinical Trial Solutions Company

VC fundings increased significantly post-Covid

The number of venture capital funding deals have increased post Covid. There were six deals in 2018 which increased to 18 in 2020. Most VC funding occurred in Q3 2020 (10 deals). Notably, Medable - one of the fastest growing decentralized trials platform providers - raised $524 million from various rounds since 2020. One of the biggest rounds occurred in October 2021, where the company received a huge $304 million Series D funding.

Geographic Overview: Virtual Clinical Trials Market

Comprehensive regional assessment of the global virtual clinical trials market suggests that US is currently the largest market for virtual clinical trials. On the other hand, European life science/medical device companies have not moved as rapidly to adopt virtual trials as U.S. However, there have been developments taking place in EU those are expected to propel the adoption steadily. For instance, in September 2019, the Trials@Home project was launched by the public-private partnership viz. Innovative Medicines Initiative (IMI) - to augment the use of digital tools in conduct of clinical trials. This large-scale collaborative project involves 31 members from the European Federation of Pharmaceutical Industries and Associations (EFPIA), academia, small- and mid-sized life science companies and patient organizations

Competitive Landscape Analysis: Virtual Clinical Trials Market

The key players in the global virtual clinical trials market are ICON, Parexel, IQVIA, Covance, Thermo Fisher, LEO Innovation Lab, Huma, Medidata, Oracle, CRF Health, Medable, Signant Health, and Clinical Ink.

Get a Customized Research Report on Virtual Clinical Trials Market @  https://meditechinsights.com/global-virtual-clinical-trials-market/

Contact
Medi-Tech Insights
aves.s@meditechinsights.com
32 498868079
End
Email:***@meditechinsights.com Email Verified
Tags:Virtual Clinical Trials
Industry:Health
Location:Brussels - Brussels - Belgium
Account Email Address Verified     Account Phone Number Verified     Disclaimer     Report Abuse
Medi-Tech Insights News
Trending
Most Viewed
Daily News



Like PRLog?
9K2K1K
Click to Share